아퓨어스 Stock: price and insider trades · South Korea

아퓨어스 is a Health Care company. Its directors and officers file their transactions with DART (FSS). 5 insiders have disclosed 15 filings since 10 November 2025.

Purchases and sales both appear in the filings: 2 purchases (1 insider) and 13 sales (4 insiders). The totals exclude 15 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The last insider purchase was made public on 29 January 2026, 285 days ago. The median gap between a trade and its publication by DART (FSS) is 10 days. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Compared with its exchange (2,648 companies, median 7 filings), a count of 15 filings is above the norm. Our records for 아퓨어스 go back to 2022, with 2 purchases and 22 sales on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.